Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

  • Stefania Gori,
  • Alessandro Inno,
  • Elena Fiorio,
  • Jennifer Foglietta,
  • Antonella Ferro,
  • Marcella Gulisano,
  • Graziella Pinotti,
  • Marta Gubiotti,
  • Maria Giovanna Cavazzini,
  • Monica Turazza,
  • Simona Duranti,
  • Valeria De Simone,
  • Laura Iezzi,
  • Giancarlo Bisagni,
  • Simon Spazzapan,
  • Luigi Cavanna,
  • Chiara Saggia,
  • Emilio Bria,
  • Elisabetta Cretella,
  • Patrizia Vici,
  • Daniele Santini,
  • Alessandra Fabi,
  • Ornella Garrone,
  • Antonio Frassoldati,
  • Laura Amaducci,
  • Silvana Saracchini,
  • Lucia Evangelisti,
  • Sandro Barni,
  • Teresa Gamucci,
  • Lucia Mentuccia,
  • Lucio Laudadio,
  • Alessandra Zoboli,
  • Fabiana Marchetti,
  • Giuseppe Bogina,
  • Gianluigi Lunardi,
  •  [ ... ],
  • Luca Boni
  • [ view all ]
  • [ view less ]

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

  • Stefania Gori, 
  • Alessandro Inno, 
  • Elena Fiorio, 
  • Jennifer Foglietta, 
  • Antonella Ferro, 
  • Marcella Gulisano, 
  • Graziella Pinotti, 
  • Marta Gubiotti, 
  • Maria Giovanna Cavazzini, 
  • Monica Turazza
PLOS
x
  • Article
  • Metrics
  • Comments
  • Media Coverage

There is an error in the second to last sentence of the Conclusion. The correct sentence is: It should be emphasized, however, that in the adjuvant systemic therapy without trastuzumab group 94% of tumors were hormone receptor positive and 89% of patients were treated with endocrine therapy only.

Reference

  1. 1. Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, et al. (2015) The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. PLoS ONE 10(9): e0136731. pmid:26340098